Elan and Transition Therapeutics Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 (AZD-103)

22-Oct-2008 - USA

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance